Literature DB >> 812091

Antibody nature of circulating inhibitor of plasma von Willebrand factor.

R D Stratton, R H Wagner, W P Webster, K M Brinkhous.   

Abstract

A circulating plasma inhibitor of the "von Willebrand factor" was observed in a multiply tranfused subject with severe von Willebrand's disease. The platelet-active von Willebrand factor is associated with a plasma protein macromolecular complex that is deficient in the disease. The inhibitor appears to be an IgG antibody, kappa type, based on neutralization tests with goat antisera to specific human immunoglobulins. The IgG and inhibitor separated out together in plasma fractions obtained by "salting-out" and chromatographic procedures. Two separate inhibitor neutralization tests for the platelet-active factor, one with human plasma and ristocetin, the other with bovine plasma, gave similar results, based on the macroscopic aggregation time test of fixed human platelets. With cryoprecipitate transfusions the inhibitor was transiently neutralized with the temporary appearance of von Willebrand factor, factor VIII, and factor VIII-like antigen in the plasma. The plasma inhibitor level increased after transfusion, suggesting an anamnestic response. Lower titer inhibitor plasmas neutralized only the platelet activity. Highest titer plasma also neutralized human factor VIII, but only in part; it did not neutralize either bovine factor VIII or the human small active factor VIII fragment. The anti-factor VIII activity of the von Willebrand factor inhibitor may be due to steric hindrance, dependent on the spatial relationship of factor VIII sites on the macromolecular complex.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 812091      PMCID: PMC433161          DOI: 10.1073/pnas.72.10.4167

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  ANTIHEMOPHILIC FACTOR LEVELS IN BLEEDER SWINE FOLLOWING INFUSIONS OF PLASMA AND SERUM.

Authors:  M E MUHRER; E LECHLER; C N CORNELL; J L KIRKLAND
Journal:  Am J Physiol       Date:  1965-03

2.  HETEROZYGOSITY AND HOMOZYGOSITY IN VON WILLEBRAND'S DISEASE.

Authors:  E M BARROW; C C HEINDEL; H R ROBERTS; J B GRAHAM
Journal:  Proc Soc Exp Biol Med       Date:  1965-03

3.  Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure.

Authors:  R D LANGDELL; R H WAGNER; K M BRINKHOUS
Journal:  J Lab Clin Med       Date:  1953-04

4.  Assay of von Willebrand factor in von Willebrand's disease and hemophilia: use of a macroscopic platelet aggregation test.

Authors:  K M Brinkhous; J E Graham; H A Cooper; J P Allain; R H Wagner
Journal:  Thromb Res       Date:  1975-03       Impact factor: 3.944

5.  Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor.

Authors:  J P Allain; H A Cooper; R H Wagner; K M Brinkhous
Journal:  J Lab Clin Med       Date:  1975-02

6.  Evidnece that human platelet aggregating activity in porcine plasma is a property of von Willbrand factor.

Authors:  G Gaetano; M B Donati; J Vermylen
Journal:  Thromb Diath Haemorrh       Date:  1974-12-31

7.  Nature of von Willebrand factor: a new assay and a specific inhibitor.

Authors:  K E Sarji; R D Stratton; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

8.  Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.

Authors:  T R Griggs; H A Cooper; W P Webster; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1973-10       Impact factor: 11.205

9.  Ristocetin--a new tool in the investigation of platelet aggregation.

Authors:  M A Howard; B G Firkin
Journal:  Thromb Diath Haemorrh       Date:  1971-10-31

10.  Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassay.

Authors:  T R Griggs; W P Webster; H A Cooper; R H Wagner; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

View more
  5 in total

1.  Venom coagglutinin: an activator of platelet aggregation dependent on von Willebrand factor.

Authors:  M S Read; R W Shermer; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

Review 2.  Alloantibodies in von Willebrand disease.

Authors:  Paula D James; David Lillicrap; Pier M Mannucci
Journal:  Blood       Date:  2013-01-07       Impact factor: 22.113

3.  Von Willebrand syndrome induced by a Bothrops venom factor: bioassay for venom coagglutinin.

Authors:  K M Brinkhous; D S Barnes; J Y Potter; M S Read
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

4.  Monitoring of von Willebrand factor inhibitors in patients with type 3 von Willebrand disease using a quantitative assay.

Authors:  Connie H Miller
Journal:  Haemophilia       Date:  2021-06-05       Impact factor: 4.263

5.  Rare Occurrence of Inhibitors in Von Willebrand Disease: A Case Report.

Authors:  Bipin P Kulkarni; Kirti Ghargi; Chandrakala Shanmukhaiah; Shrimati D Shetty
Journal:  Front Med (Lausanne)       Date:  2022-01-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.